At 4°, the activity of exogenous 8-arginine vasopressin in rat plasma decreased to 50% in 2 days, whereas there was no loss of oxytocin under the same conditions after 3 days. At 37°, oxytocin was not inactivated in 9 hr., whereas 50% of 8-arginine vasopressin was lost in 2 hr.
Forty per cent of exogenous oxytocin in rat plasma was unable to pass through a cellophane (Visking 8/32 in.) membrane, when subjected to a pressure of 100 torr for 18 hr.
In rats under pentobarbitone anaesthesia, progressive haemorrhage of more than 2·0 ml./100 g. induced a secretion of both oxytocin and 8-arginine vasopressin, to produce maximum concentrations of 450 and 700 μ-u./ml., respectively, in the carotid plasma.
In the intact rat (weighing 200–250 g.) anaesthetized with pentobarbitone, 50% of oxytocin in the circulation disappeared within 2 min. after stopping an i.v. infusion of 250–6000 μ-u./100 g./min. The half-time was increased to 4 min. by sham operation, and to 6 or 7 min. by occluding either the renal, or the portal, coeliac and mesenteric vessels. In non-lactating animals, the half-time was 8 min. after clamping both the renal and splanchnic vessels, whereas it was 6 min. in the lactating rat, under the same conditions.
The apparent volume of distribution of oxytocin was 7·3 ml./100 g. in intact rats, and 10–13 ml./100 g. after operation.
The plasma clearance of oxytocin was unaltered in the sham-operated rat, but it decreased after the operative procedures.
Journal of Endocrinology is committed to supporting researchers in demonstrating the impact of their articles published in the journal.
The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.
More information is on the Reasons to publish page.
| Sept 2018 onwards | Past Year | Past 30 Days | |
|---|---|---|---|
| Full Text Views | 10 | 2 | 0 |
| PDF Downloads | 11 | 2 | 0 |
Online ISSN: 1479-6805
Print ISSN: 0022-0795
Strengthening biomedical communities
to advance science and health
CONTACT US
Bioscientifica Ltd | Starling House | 1600 Bristol Parkway North | Bristol BS34 8YU | UK
Bioscientifica Ltd | Registered in England no 3190519
